Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in Narbonne

4 clinical trials in Narbonne, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Narbonne at a glance
4
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Narbonne

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Narbonne

What the registry says about research in the country

01 Cardiovascular Research

Groundbreaking research focusing on heart failure prevention through combination therapy studies. The investigations aim to evaluate novel treatments for reducing cardiovascular mortality risks.

  • Heart Failure Prevention
  • Cardiovascular Death Risk Reduction
  • Combination Therapy Assessment

These trials represent significant advancement in preventive cardiology approaches.

02 Rheumatology Studies

Comprehensive research into psoriatic arthritis treatments, focusing on biologic-naive patients. The studies evaluate innovative therapeutic approaches for managing inflammatory joint conditions.

  • Biologic DMARD Studies
  • Subcutaneous Treatment Evaluation
  • Early Intervention Protocols

The research aims to establish new treatment paradigms for autoimmune arthritis conditions.

03 Advanced Therapeutics

Specialized investigations comparing novel treatments with existing therapies for treatment-resistant arthritis. These trials specifically target patients who haven't responded adequately to conventional treatments.

  • Treatment-Resistant Cases
  • Comparative Efficacy Studies
  • Alternative Therapeutic Options

This research addresses critical gaps in current treatment options for challenging cases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.